#citius pharma

[untitled59750]

Dr Reddy’s to sell its rights of anti-cancer agent to Citius Pharma

Dr Reddy’s to sell its rights of anti-cancer agent to Citius Pharma

HYDERABAD: Pharma fundamental Dr Reddy’s Laboratories Ltd has entered right into a definitive settlement with Citius Pharmaceuticals Inc for the sale of its complete proper of investigational anti-most cancers agent E7777 (denileukin diftitox) and a few associated assets. WATCH MORE Dr Reddy’s will get hold of an in advance charge of $forty million from Citius on closure of the transaction for…

View On WordPress

[hummingzone]

Dr Reddy's signs pact with Citius Pharma to sell rights to anti-cancer agent

Dr Reddy’s signs pact with Citius Pharma to sell rights to anti-cancer agent

Dr Reddy’s Laboratories Ltd. on Saturday announced that it has entered into a definitive agreement with Citius Pharmaceuticals to sell its rights to E7777  (an engineered IL-2-diphtheria toxin fusion protein) and certain related assets.  Under the terms of agreement, Dr Reddy’s will receive $40 million upfront upon the closing of the transaction, followed by approval milestone payment of up to…

View On WordPress